Trial NCT02592707

View at ClinicalTrials.gov 
Org. Study IDs: D-FR-01072-001
Secondary IDs: 2015-002867-41 OPS-C-001

Last trial update was posted on 2023-07-19

MeSH Interventions

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid Antiemetics Dexamethasone Ondansetron

MeSH Conditions

Neuroendocrine Tumors

Other Conditions


Stopping Reasons

Terminated (Due to small number of ongoing patients. Patients ongoing at time of termination could choose to join study D-FR-01072-004 for long term follow-up.

Limitations And Caveats

Due to strategic reasons, the Ipsen management team decided to early terminate the D-FR-01072-001 / OPS-C-001 study. This decision was not due to any safety or tolerability concern, or any event associated with the use of the study drug.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID